# US 2010/0081635 A1 · Compounds for treating proliferative disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0081635 A1
- Document ID: US20100081635A1
- Status: Published application
- Kind: A1
- Application number: 12/310,304
- Filed: 2007-08-20
- Published: 2010-04-01
- Earliest claimed: 2006-08-21
- Assignees: Synta Pharmaceuticals Corp.
- Inventors: Shoujun Chen; Keizo Koya; Zachary Demko; Lijun Sun
- Web page: https://patentgrep.com/patent/US20100081635A1

## CPC

- C07C 327/56: having nitrogen atoms of thiocarboxamide groups further bound to another hetero atom
- A61K 31/16: Amides, e.g. hydroxamic acids
- A61K 31/166: having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
- A61K 31/18: Sulfonamides (compounds containing a para-N-benzene-sulfonyl-N- group A61K31/63)
- A61K 31/277: having a ring, e.g. verapamil
- A61K 31/341: not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A61K 31/40: having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K 31/4245: Oxadiazoles
- A61K 31/664: Amides of phosphorus acids
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 15/00: Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives
- A61P 15/08: for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/06: Antipsoriatics
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 25/14: for treating abnormal movements, e.g. chorea, dyskinesia
- A61P 25/16: Anti-Parkinson drugs
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 31/04: Antibacterial agents
- A61P 31/10: Antimycotics
- A61P 31/12: Antivirals
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 243/28: to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
- C07C 243/34: to carbon atoms of a carbon skeleton further substituted by nitrogen atoms
- C07C 255/66: having cyano groups and nitrogen atoms being part of hydrazine or hydrazone groups bound to the same carbon skeleton
- C07C 257/22: having nitrogen atoms of amidino groups further bound to nitrogen atoms, e.g. hydrazidines
- C07C 261/04: Cyanamides (unsubstituted cyanamide C01C3/16)
- C07C 281/06: Compounds containing any of the groups [IMAGE cpc-sch-C07C-0973.gif], e.g. semicarbazides
- C07C 307/04: Diamides of sulfuric acids
- C07C 311/49: to nitrogen atoms
- C07C 311/51: Y being a hydrogen or a carbon atom
- C07C 311/55: having sulfur atoms of the sulfonylurea groups bound to acyclic carbon atoms
- C07C 337/06: Compounds containing any of the groups [IMAGE cpc-sch-C07C-0987.gif], e.g. thiosemicarbazides
- C07D 207/34: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D 207/36: Oxygen or sulfur atoms
- C07D 233/74: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
- C07D 263/48: Nitrogen atoms not forming part of a nitro radical
- C07D 271/10: 1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D 271/113: with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D 307/66: Nitrogen atoms
- C07F 9/228: {containing the structure P-N-N, e.g. azides, hydrazides}
- C07F 9/4423: {Amides of poly (thio)phosphonic acids}
- C07F 9/4496: {Compounds containing the structure P(=X)(N-N-) (X = O, S, Se)}
- C07F 9/46: Phosphinous acids [R2POH], [R2P(= O)H]: Thiophosphinous acids {including[R2PSH]; [R2P(=S)H]; Aminophosphines [R2PNH2]; Derivatives thereof}
- C07C 2601/02: with a three-membered ring
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

Disclosed are compounds of formulae (I), (III), (IV), (VII), (X), (XI), (XII), (XIII) and (XIV), wherein the variabables are as defined in the claims, and methods of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier.

## Claims

### Claim 1

A compound represented by formula (I):
or a tautomer, pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein:
R1 and R2 are independently an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, halo, nitro, cyano, guanidino, —OR17, —NR19R20, —C(O)R17, —C(O)OR17, —OC(O)R17, —C(O)NR19R20, —NR18C(O)R17, —OP(O)(OR17)2, —SP(O)(OR17)2, —SR17, —S(O)pR17, —OS(O)pR17, —S(O)pOR17, —NR18S(O)pR17, or —S(O)pNR19R20;
R3 and R4 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R5 and R6 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R13 is a covalent bond, or a substituted or unsubstituted C1-C6 alkylene group;
R17 and R18, for each occurrence, are, independently, —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl;
R19 and R20, for each occurrence, are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl; or R19 and R20, taken together with the nitrogen to which they are attached, form an optionally substituted heterocyclyl or an optionally substituted heteroaryl; and
p is 1 or 2;
provided that when R13 is CH2—, R3 and R4 are both phenyl and R5 and R6 are both —H, then R1 and R2 are not both phenyl; and
provided that when R13 is CH2—, R3 and R4 are both phenyl and R5 and R6 are both —H, then R1 and R2 are not both methyl.

### Claim 2 (depends on 1)

The compound of claim 1, wherein:
R1 and R2 are each an optionally substituted aryl or an optionally substituted heteroaryl; and
R3 and R4 are each an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim 3 (depends on 2)

The compound of claim 2, wherein
R5 is —H and R6 is —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl; and
R3 and R4 are each an alkyl group.

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The compound of claim 1, wherein
R1 and R2 are both an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl;
R5 is —H; and
R6 is —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim at position 6

-7. (canceled)

### Claim 8 (depends on 1)

The compound of claim 1, wherein R13 is a covalent bond, —CH2CH2CH2— or —CH2CH2.

### Claim 9

(canceled)

### Claim 10 (depends on 1)

The compound of claim 1, wherein
R13 is —C(R7)(R8)—;
R7 and R8 are each independently —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, or R7 is —H and R8 is an optionally substituted aryl or an optionally substituted heteroaryl.

### Claim 11 (depends on 1)

The compound of claim 1, wherein the compound is represented by formula (II):
wherein:
R7 and R8 are each independently —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, or R7 is —H and R8 is an optionally substituted aryl or an optionally substituted heteroaryl.

### Claim 12 (depends on 11)

The compound of claim 11, wherein:
R1 and R2 are both phenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both phenyl; R3 and R4 are both ethyl; R7 and R8 are both —H;
R1 and R2 are both 4-cyanophenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both 4-methoxyphenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both phenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both phenyl; R3 and R4 are both ethyl; R7 is methyl; R8 is —H;
R1 and R2 are both 4-cyanophenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,5-dimethoxyphenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,5-dimethoxyphenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both 3-cyanophenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 3-fluorophenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 4-chlorophenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both 2-dimethoxyphenyl; R3 and R4 are both methyl; R7 and R9 are both —H;
R1 and R2 are both 3-methoxyphenyl; R3 and R4 are both methyl; R7 and R9 are both —H;
R1 and R2 are both 2,3-dimethoxyphenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,3-dimethoxyphenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both 2,5-difluorophenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,5-difluorophenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both 2,5-dichlorophenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,5-dimethylphenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,5-dimethoxyphenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both phenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,5-dimethoxyphenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both cyclopropyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both cyclopropyl; R3 and R4 are both ethyl; R7 and R8 are both —H;
R1 and R2 are both cyclopropyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl; R7 is methyl and R8 is —H;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl; R7 is ethyl and R8 is —H;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl; R7 is n-propyl and R8 is —H;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl; R7 and R8 are both methyl;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both ethyl; R7 and R8 are both —H;
R1 and R2 are both 1-methylcyclopropyl; R3 is methyl, and R4 is ethyl; R7 and R8 are both —H;
R1 and R2 are both 2-methylcyclopropyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2-phenylcyclopropyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 1-phenylcyclopropyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both cyclobutyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both cyclopentyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both cyclohexyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both cyclohexyl; R3 and R4 are both phenyl; R7 and R8 are both —H;
R1 and R2 are both methyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both methyl; R3 and R4 are both t-butyl; R7 and R8 are both —H;
R1 and R2 are both methyl; R3 and R4 are both phenyl; R7 and R8 are both —H;
R1 and R2 are both t-butyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are ethyl; R3 and R4 are both methyl; R7 and R8 are both —H; or
R1 and R2 are both n-propyl; R3 and R4 are both methyl; R7 and R8 are both —H.

### Claim 13

A compound represented by formula (III) or (IV):
or a tautomer, pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein:
X1, X2, X3 and X4 are independently selected from the group consisting of
Z1, Z2, Z3, and Z4 are each independently O or S;
R1 and R2 are independently an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, halo, nitro, cyano, guanidino, —OR17, —NR19R20, —C(O)R17, —C(O)OR17, —OC(O)R17, —C(O)NR19R20, —NR18C(O)R17, —OP(O)(OR17)2; —SP(O)(OR17)2, —S(O)pR17; —OS(O)pR17, —S(O)pOR17, —NR18S(O)pR17, or —S(O)pNR19R20; provided that for formula (III), R1 and R2 are not OH, —SH, or —NH2;
R3 and R4 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl; and
R5 and R6 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R9, R10, and R11 are each independently —H, —NR19R20, halo, —OR17, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R13 is a covalent bond, or a substituted or unsubstituted C1-C6 alkylene group;
R17 and R18, for each occurrence, are, independently, —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl;
R19 and R20, for each occurrence, are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl; or R19 and R20, taken together with the nitrogen to which they are attached, form an optionally substituted heterocyclyl or an optionally substituted heteroaryl; and
p is 1 or 2.

### Claim 14 (depends on 13)

The compound of claim 13, wherein:
R1 and R2 are each an optionally substituted aryl or an optionally substituted heteroaryl; and
R3 and R4 are each an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim 15 (depends on 14)

The compound of claim 14, wherein
R5 is —H and R6 is —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl; and
R3 and R4 are each an alkyl group.

### Claim 16

(canceled)

### Claim 17 (depends on 13)

The compound of claim 13, wherein
R1 and R2 are both an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl;
R5 is —H; and
R6 is —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim at position 17

-19. (canceled)

### Claim 20 (depends on 13)

The compound of claim 13, wherein R13 is a covalent bond, —CH2CH2CH2— or —CH2CH2.

### Claim 21

(canceled)

### Claim 22 (depends on 13)

The compound of claims 13, wherein
R13 is —C(R7)(R8)—;
R7 and R8 are each independently —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, or R7 is H and R8 is an optionally substituted aryl or an optionally substituted heteroaryl.

### Claim at position 21

-26. (canceled)

### Claim 27 (depends on 13)

The compound of claim 13, wherein R9, R10, and R11 are each independently —H or an optionally substituted alkyl.

### Claim 28 (depends on 13)

The compound of claim 13, wherein X1 and X2 are both

### Claim 29 (depends on 13)

The compound of claim 13, wherein X3 and X4 are both

### Claim 30 (depends on 13)

The compound of claim 13, wherein the compound is a compound of formula (V):
wherein:
R7 and R8 are each independently —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, or R7 is —H and R8 is an optionally substituted aryl or an optionally substituted heteroaryl.

### Claim 31 (depends on 30)

The compound of claim 30, wherein X3 and X4 are both

### Claim 32 (depends on 31)

The compound of claim 31, wherein R9 is an optionally substituted alkyl.

### Claim 33 (depends on 32)

The compound of claim 32, wherein the alkyl group is optionally substituted with a lower alkyl, a lower alkenyl, a lower alkynyl, a C3-C8 cycloalkyl, a C3-C8 cycloalkenyl, a phenyl, a benzyl or a lower haloalkyl group.

### Claim 34 (depends on 32)

The compound of claim 32, wherein R1 and R2 are each an optionally substituted aryl group; and R3 and R4 are each an optionally substituted alkyl group.

### Claim 35 (depends on 34)

The compound of claim 34, wherein R1 and R2 are each an optionally substituted phenyl; and R3 and R4 are each a methyl or ethyl group.

### Claim 36 (depends on 35)

The compound of claim 35, wherein R7 and R8 are both —H.

### Claim 37

(canceled)

### Claim 38 (depends on 13)

The compound of claim 13, wherein the compound is a compound of formula (VI):
wherein:
R7 and R8 are each independently —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, or R7 is —H and R8 is an optionally substituted aryl or an optionally substituted heteroaryl.

### Claim 39

(canceled)

### Claim 40

A compound represented by formula (VII):
or a tautomer, pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein:
each Z is independently O or S;
X5 is —S(O)—, —S(O)2—, —P(O)(OR12)—, —S(O)2R13S(O)2—, —S(O)2OS(O)2—, —S(O)2SS(O)2—, —S(O)2N(R5)S(O)2—, —P(O)(OR12)R13P(O)(OR12)—, P(O)(OR12)OP(O)(OR12)—, —P(O)(OR12)SP(O)(OR12)—, or —P(O)(OR12)N(R5)P(O)(OR12)—;
R1 and R2 are independently an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, halo, nitro, cyano, guanidino, —OR17, —NR19R20, —C(O)R17, —C(O)OR17, —OC(O)R17, —C(O)NR19R20, —NR18C(O)R17, —OP(O)(OR17)2, —SP(O)(OR17)2—, —SR17, —S(O)pR17, —OS(O)pR17, —S(O)pOR17, —NR18S(O)pR17, or —S(O)pNR19R20; provided that when either Z3 or Z4 is O, then R1 or R2 is not —OR17, provided that when Z is O, then R1 or R2 is not —OR17 or —NR19R20;
R3 and R4 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R5 and R6 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R12 is independently H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, or halo;
R13 is a covalent bond, or a substituted or unsubstituted C1-C6 alkylene group;
R17 and R18, for each occurrence, are, independently, —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl;
R19 and R20, for each occurrence, are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl; or R19 and R20, taken together with the nitrogen to which they are attached, form an optionally substituted heterocyclyl or an optionally substituted heteroaryl; and
p is 1 or 2.

### Claim 41 (depends on 40)

The compound of claim 40, wherein both Z groups are S.

### Claim 42 (depends on 40)

The compound of claim 40, wherein both Z groups are O.

### Claim 43 (depends on 40)

The compound of claim 40, wherein X5 is —S(O)—, —S(O)2—, or —P(O)(OR12)—.

### Claim 44 (depends on 40)

The compound of claim 40, wherein X5 is —S(O)2R13S(O)2— or —P(O)(OR12)R13P(O)(OR12)—.

### Claim 45 (depends on 40)

The compound of claim 40, wherein:
R1 and R2 are each an optionally substituted aryl or an optionally substituted heteroaryl; and
R3 and R4 are each an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim 46 (depends on 45)

The compound of claim 45, wherein
R5 is —H and R6 is —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl; and
R3 and R4 are each an alkyl group.

### Claim 47 (depends on 46)

The compound of claim 46, wherein R1 and R2 are each a substituted or unsubstituted phenyl group and R3 and R4 are each methyl or ethyl.

### Claim 48 (depends on 40)

The compound of claim 40, wherein
R1 and R2 are both an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl;
R5 is —H; and
R6 is —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim at position 44

-50. (canceled)

### Claim 51 (depends on 40)

The compound of claim 40, wherein R13 is a covalent bond, —CH2CH2CH2— or —CH2CH2.

### Claim 52

(canceled)

### Claim 53 (depends on 40)

The compound of claim 40, wherein
R13 is —C(R7)(R8)—;
R7 and R8 are each independently —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, or R7 is —H and R8 is an optionally substituted aryl or an optionally substituted heteroaryl.

### Claim 54 (depends on 40)

The compound of claim 40, wherein the compound is represented by formula (VIII) or (IX):
wherein:
R7 and R8 are each independently —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, or R7 is —H and R8 is an optionally substituted aryl or an optionally substituted heteroaryl.

### Claim 55 (depends on 54)

The compound of claim 54, wherein:
R1 and R2 are both phenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both phenyl; R3 and R4 are both ethyl; R7 and R8 are both —H;
R1 and R2 are both 4-cyanophenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both 4-methoxyphenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both phenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both phenyl; R3 and R4 are both ethyl; R7 is methyl; R8 is —H;
R1 and R2 are both 4-cyanophenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,5-dimethoxyphenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,5-dimethoxyphenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both 3-cyanophenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 3-fluorophenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 4-chlorophenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both 2-dimethoxyphenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 3-methoxyphenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,3-dimethoxyphenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,3-dimethoxyphenyl; R3 and R4 are both methyl; R7 is methyl; R8 iS —H;
R1 and R2 are both 2,5-difluorophenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,5-difluorophenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both 2,5-dichlorophenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,5-dimethylphenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,5-dimethoxyphenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both phenyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2,5-dimethoxyphenyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both cyclopropyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both cyclopropyl; R3 and R4 are both ethyl; R7 and R8 are both —H;
R1 and R2 are both cyclopropyl; R3 and R4 are both methyl; R7 is methyl; R8 is —H;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl; R7 is methyl and R8 is —H;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl; R7 is ethyl and R8 is
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl; R7 is n-propyl and R8 is —H;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl; R7 and R8 are both methyl;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both ethyl; R7 and R8 are both —H;
R1 and R2 are both 1-methylcyclopropyl; R3 is methyl, and R4 is ethyl; R7 and R8 are both —H;
R1 and R2 are both 2-methylcyclopropyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 2-phenylcyclopropyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both 1-phenylcyclopropyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both cyclobutyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both cyclopentyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both cyclohexyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both cyclohexyl; R3 and R4 are both phenyl; R7 and R8 are both —H;
R1 and R2 are both methyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are both methyl; R3 and R4 are both t-butyl; R7 and R8 are both —H;
R1 and R2 are both methyl; R3 and R4 are both phenyl; R7 and R8 are both —H;
R1 and R2 are both t-butyl; R3 and R4 are both methyl; R7 and R8 are both —H;
R1 and R2 are ethyl; R3 and R4 are both methyl; R7 and R8 are both —H; or
R1 and R2 are both n-propyl; R3 and R4 are both methyl; R7 and R8 are both —H.

### Claim 56

A compound represented by formula (X):
or a tautomer, pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein:
X6 is —O—, —S—, —N(R5)—, or —C(R5)2—;
X9 and X10 are independently —C(R5)—;
each Z is independently O or S;
R1 and R2 are independently an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, halo, nitro, cyano, guanidino, —OR17, —NR19R20, —C(O)R17, —C(O)OR17, —OC(O)R17, —C(O)NR19R20, —NR18C(O)R17, —OP(O)(OR17)2, —SP(O)(OR17)2—, —SR17, —S(O)pR17, —OS(O)pR17, —S(O)pOR17, —NR18S(O)pR17, or —S(O)pNR19R20; provided that when Z is O, R1 or R2 is not —OR17;
R3 and R4 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R5 and R6 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R17 and R18, for each occurrence, are, independently, —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl;
R19 and R20, for each occurrence, are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl; or R19 and R20, taken together with the nitrogen to which they are attached, form an optionally substituted heterocyclyl or an optionally substituted heteroaryl; and
p is 1 or 2.

### Claim 57 (depends on 56)

The compound of claim 56, wherein:
R1 and R2 are each an optionally substituted aryl or an optionally substituted heteroaryl; and
R3 and R4 are each an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim 58 (depends on 57)

The compound of claim 57, wherein
R5 is —H and R6 is —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl; and
R3 and R4 are each an alkyl group.

### Claim 59

(canceled)

### Claim 60 (depends on 56)

The compound of claim 56, wherein
R1 and R2 are both an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl;
R5 is —H; and
R6 is —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim at position 55

-64. (canceled)

### Claim 65 (depends on 56)

The compound of claim 56, wherein X6 is —O— or —N(R5)—.

### Claim 66 (depends on 65)

The compound of claim 65, wherein X6 is —O— or —NH—.

### Claim 67 (depends on 56)

The compound of claim 56, wherein R5 and R6 are both —H.

### Claim 68 (depends on 67)

The compound of claim 67, wherein:
R1 and R2 are both phenyl; R3 and R4 are both methyl;
R1 and R2 are both phenyl; R3 and R4 are both ethyl;
R1 and R2 are both 4-cyanophenyl; R3 and R4 are both methyl;
R1 and R2 are both 4-methoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 4-cyanophenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,5-dimethoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 3-cyanophenyl; R3 and R4 are both methyl;
R1 and R2 are both 3-fluorophenyl; R3 and R4 are both methyl;
R1 and R2 are both 4-chlorophenyl; R3 and R4 are both methyl;
R1 and R2 are both 2-dimethoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 3-methoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,3-dimethoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,5-difluorophenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,5-dichlorophenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,5-dimethylphenyl; R3 and R4 are both methyl;
R1 and R2 are both cyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both cyclopropyl; R3 and R4 are both ethyl;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both ethyl;
R1 and R2 are both 1-methylcyclopropyl; R3 is methyl, and R4 is ethyl;
R1 and R2 are both 2-methylcyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both 2-phenylcyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both 1-phenylcyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both cyclobutyl; R3 and R4 are both methyl;
R1 and R2 are both cyclopentyl; R3 and R4 are both methyl;
R1 and R2 are both cyclohexyl; R3 and R4 are both methyl;
R1 and R2 are both cyclohexyl; R3 and R4 are both phenyl;
R1 and R2 are both methyl; R3 and R4 are both methyl;
R1 and R2 are both methyl; R3 and R4 are both t-butyl;
R1 and R2 are both methyl; R3 and R4 are both phenyl;
R1 and R2 are both t-butyl; R3 and R4 are both methyl;
R1 and R2 are ethyl; R3 and R4 are both methyl; or
R1 and R2 are both n-propyl; R3 and R4 are both methyl.

### Claim 69

A compound represented by formula (XI):
or a tautomer, pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein:
X6 is —O—, —S—, —N(R5)—, or —C(R5)2—;
X7 and X8 are independently —O—, —S—, —N(R5)—, or —C(R5)2—;
X9 and X10 are independently —C(R5)—;
R1 and R2 are independently an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, halo, nitro, cyano, guanidino, —OR17, —NR19R20, —C(O)R17, —C(O)OR17, —OC(O)R17, —C(O)NR19R20, —NR18C(O)R17, —OP(O)(OR17)2, —SP(O)(OR17)2, —SR17, —S(O)pR17, —OS(O)pR17, —S(O)pOR17, —NR18S(O)pR17, or —S(O)pNR19R20;
R3 and R4 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R5 and R6 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R17 and R18, for each occurrence, are, independently, —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl;
R19 and R20, for each occurrence, are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl; or R19 and R20, taken together with the nitrogen to which they are attached, form an optionally substituted heterocyclyl or an optionally substituted heteroaryl; and
p is 1 or 2.

### Claim 70 (depends on 69)

The compound of claim 69, wherein:
R1 and R2 are each an optionally substituted aryl or an optionally substituted heteroaryl; and
R3 and R4 are each an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim 71 (depends on 70)

The compound of claim 70, wherein
R5 is —H and R6 is —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl; and
R3 and R4 are each an alkyl group.

### Claim 72

(canceled)

### Claim 73 (depends on 69)

The compound of claim 69, wherein
R1 and R2 are both an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl;
R5 is —H; and
R6 is —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim at position 65

-75. (canceled)

### Claim 76 (depends on 69)

The compound of claim 69, wherein X6 is —O— or —N(R5)—.

### Claim 77 (depends on 76)

The compound of claim 76, wherein X6 is —O— or —NH—.

### Claim 78 (depends on 69)

The compound of claim 69, wherein X7 and X8 are both —O— or —N(R5)—.

### Claim 79 (depends on 78)

The compound of claim 78, wherein X7 and X8 are both —N(H)—.

### Claim 80 (depends on 69)

The compound of claim 69, wherein:
R1 and R2 are both phenyl; R3 and R4 are both methyl;
R1 and R2 are both phenyl; R3 and R4 are both ethyl;
R1 and R2 are both 4-cyanophenyl; R3 and R4 are both methyl;
R1 and R2 are both 4-methoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 4-cyanophenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,5-dimethoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 3-cyanophenyl; R3 and R4 are both methyl;
R1 and R2 are both 3-fluorophenyl; R3 and R4 are both methyl;
R1 and R2 are both 4-chlorophenyl; R3 and R4 are both methyl;
R1 and R2 are both 2-dimethoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 3-methoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,3-dimethoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,5-difluorophenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,5-dichlorophenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,5-dimethylphenyl; R3 and R4 are both methyl;
R1 and R2 are both cyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both cyclopropyl; R3 and R4 are both ethyl;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both ethyl;
R1 and R2 are both 1-methylcyclopropyl; R3 is methyl, and R4 is ethyl;
R1 and R2 are both 2-methylcyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both 2-phenylcyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both 1-phenylcyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both cyclobutyl; R3 and R4 are both methyl;
R1 and R2 are both cyclopentyl; R3 and R4 are both methyl;
R1 and R2 are both cyclohexyl; R3 and R4 are both methyl;
R1 and R2 are both cyclohexyl; R3 and R4 are both phenyl;
R1 and R2 are both methyl; R3 and R4 are both methyl;
R1 and R2 are both methyl; R3 and R4 are both t-butyl;
R1 and R2 are both methyl; R3 and R4 are both phenyl;
R1 and R2 are both t-butyl; R3 and R4 are both methyl;
R1 and R2 are ethyl; R3 and R4 are both methyl; or
R1 and R2 are both n-propyl; R3 and R4 are both methyl.

### Claim 81 (depends on 80)

The compound of claim 80, wherein X7 and X8 are both —N(H)—.

### Claim 82 (depends on 81)

The compound of claim 81, wherein X6 is —O— or —NH—.

### Claim 83

A compound represented by formula (XII):
or a tautomer, pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein:
X6 is —O—, —S—, —N(R5)—, or —C(R5)2—;
X7 and X8 are independently —O—, —S—, —N(R5)—, or —C(R5)2—;
X11 and X12 are independently —C(R5)— or —N—, provided that at least one of X11 or X12 is —N—;
each Z is independently O or S;
R1 and R2 are independently an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, halo, nitro, cyano, guanidino, —OR17, —NR19R20, —C(O)R17, —C(O)OR17, —OC(O)R17, —C(O)NR19R20, —NR18C(O)R17, —OP(O)(OR17)2, —SP(O)(OR17)2, —SR17, —S(O)pR17, —OS(O)pR17, —S(O)pOR17, —NR18S(O)pR17, or —S(O)pNR19R20;
R3 and R4 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R5 and R6 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R17 and R18, for each occurrence, are, independently, —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl;
R19 and R20, for each occurrence, are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl; or R19 and R20, taken together with the nitrogen to which they are attached, form an optionally substituted heterocyclyl or an optionally substituted heteroaryl; and
p is 1 or 2;
provided that when both Z groups are O, then neither R1 or R2 is —OR17; and
provided that when both Z groups are O and X7 and X8 are both CH2—, then neither R1 or R2 is —NR19R20, or phenyl.

### Claim 84 (depends on 83)

The compound of claim 83, wherein:
R1 and R2 are each an optionally substituted aryl or an optionally substituted heteroaryl; and
R3 and R4 are each an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim 85 (depends on 84)

The compound of claim 84, wherein
R5 is —H and R6 is —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl; and
R3 and R4 are each an alkyl group.

### Claim 86

(canceled)

### Claim 87 (depends on 83)

The compound of claim 83, wherein
R1 and R2 are both an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl;
R5 is —H; and
R6 is —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim at position 78

-89. (canceled)

### Claim 90 (depends on 83)

The compound of claim 83, wherein X6 is —O— or —N(R5)—.

### Claim 91 (depends on 90)

The compound of claim 90, wherein X6 is —O— or —NH—.

### Claim 92 (depends on 83)

The compound of claim 83, wherein X7 and X8 are both —O— or —N(R5)—.

### Claim 93 (depends on 92)

The compound of claim 92, wherein X7 and X8 are both —N(H)—.

### Claim 94 (depends on 83)

The compound of claim 83, wherein X11 and X12 are both —N—.

### Claim 95 (depends on 83)

The compound of claim 83, wherein:
R1 and R2 are both phenyl; R3 and R4 are both methyl;
R1 and R2 are both phenyl; R3 and R4 are both ethyl;
R1 and R2 are both 4-cyanophenyl; R3 and R4 are both methyl;
R1 and R2 are both 4-methoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 4-cyanophenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,5-dimethoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 3-cyanophenyl; R3 and R4 are both methyl;
R1 and R2 are both 3-fluorophenyl; R3 and R4 are both methyl;
R1 and R2 are both 4-chlorophenyl; R3 and R4 are both methyl;
R1 and R2 are both 2-dimethoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 3-methoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,3-dimethoxyphenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,5-difluorophenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,5-dichlorophenyl; R3 and R4 are both methyl;
R1 and R2 are both 2,5-dimethylphenyl; R3 and R4 are both methyl;
R1 and R2 are both cyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both cyclopropyl; R3 and R4 are both ethyl;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both 1-methylcyclopropyl; R3 and R4 are both ethyl;
R1 and R2 are both 1-methylcyclopropyl; R3 is methyl, and R4 is ethyl;
R1 and R2 are both 2-methylcyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both 2-phenylcyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both 1-phenylcyclopropyl; R3 and R4 are both methyl;
R1 and R2 are both cyclobutyl; R3 and R4 are both methyl;
R1 and R2 are both cyclopentyl; R3 and R4 are both methyl;
R1 and R2 are both cyclohexyl; R3 and R4 are both methyl;
R1 and R2 are both cyclohexyl; R3 and R4 are both phenyl;
R1 and R2 are both methyl; R3 and R4 are both methyl;
R1 and R2 are both methyl; R3 and R4 are both t-butyl;
R1 and R2 are both methyl; R3 and R4 are both phenyl;
R1 and R2 are both t-butyl; R3 and R4 are both methyl;
R1 and R2 are ethyl; R3 and R4 are both methyl; or
R1 and R2 are both n-propyl; R3 and R4 are both methyl.

### Claim 96 (depends on 95)

The compound of claim 95, wherein X7 and X8 are both N(H)—.

### Claim 97 (depends on 96)

The compound of claim 96, wherein X6 is —O— or —NH—.

### Claim 98 (depends on 95)

The compound of claim 95, wherein X11 and X12 are both —N(R5)—.

### Claim 99

A compound represented by formula (XIII):
or a tautomer, pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein:
X13 is —C(O)—; —S(O)—, —S(O)2—, —P(O)(OR12)—, —S(O)2R13S(O)2—, —S(O)2OS(O)2—, —S(O)2—, S(O)2—, —S(O)2N(R5)S(O)2—, —P(O)(OR12)R13P(O)(OR12)—, P(O)(OR12)OP(O)(OR12)—, —P(O)(OR12)SP(O)(OR12)—, —C(O)R13S(O)2—, —C(O)C(═NNHR26)C(O)—, —S(O)2NR27C(O)— or —P(O)(OR12)N(R5)P(O)(OR12)—;
R1 and R2 are independently an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, halo, nitro, cyano, guanidino, —OR17, —NR19R20, —C(O)R17, —C(O)OR17, —OC(O)R17, —C(O)NR19R20, —NR18C(O)R17, —OP(O)(OR17)2, —SP(O)(OR17)2, —SR17, —S(O)pR17, —OS(O)pR17, —S(O)pOR17, —NR18S(O)pR17, or —S(O)pNR19R20; provided that when R3, R4, R5, and R6 are all —H, then neither R1 or R2 is —OR17, —NR19R20, —NR18C(O)R17, or phenyl;
R3 and R4 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R5 and R6 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl, or R5 and R6, taken together with the nitrogen atoms to which they are bonded and X13, form the following ring structure:
R12 is independently H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, or halo;
R13 is a covalent bond, or a substituted or unsubstituted C1-C6 alkylene group;
R17 and R18, for each occurrence, are, independently, —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl;
R19 and R20, for each occurrence, are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl; or R19 and R20, taken together with the nitrogen to which they are attached, form an optionally substituted heterocyclyl or an optionally substituted heteroaryl;
R26 is an optionally substituted alkyl or an optionally substituted phenyl group;
R27 is H or an optionally substituted alkyl group; and
p is 1 or 2.

### Claim 100 (depends on 99)

The compound of claim 99, wherein X13 is C(O)—.

### Claim 101 (depends on 100)

The compound of claim 100, wherein:
R1 and R2 are each an optionally substituted aryl or an optionally substituted heteroaryl; and
R3 and R4 are each an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim 102 (depends on 101)

The compound of claim 101, wherein
R5 is —H and R6 is —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl; and
R3 and R4 are each an alkyl group.

### Claim at position 92

103-104. (canceled)

### Claim 105 (depends on 100)

The compound of claim 100, wherein
R1 and R2 are both an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl;
R5 is —H; and
R6 is —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim at position 94

106-107. (canceled)

### Claim 108 (depends on 99)

The compound of claim 99, wherein X13 is —C(O)R13S(O)2—, —C(O)C(═NNHR26)C(O)—, —S(O)2NR27C(O)—, or R5 and R6, taken together with the nitrogen atoms to which they are bonded and X13, form the following ring structure:

### Claim 109 (depends on 108)

The compound of claim 108, wherein:
R1 and R2 are each an optionally substituted aryl or an optionally substituted heteroaryl; and
R3 and R4 are each an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim 110 (depends on 109)

The compound of claim 109, wherein
R5 is —H and R6 is —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl; and
R3 and R4 are each an alkyl group.

### Claim at position 98

111-112. (canceled)

### Claim 113 (depends on 108)

The compound of claim 108, wherein
R1 and R2 are both an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl;
R5 is —H; and
R6 is —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim at position 100

114-115. (canceled)

### Claim 116

A compound represented by formula (XIV):
or a tautomer, pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein:
each Z is independently O or S;
X14 is C(O)—; —S(O)—, —S(O)2—, —P(O)(OR12)—;
R1 and R2 are independently an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, halo, nitro, cyano, guanidino, —OR17, —NR19R20, —C(O)R17, —C(O)OR17, —OC(O)R17, —C(O)NR19R20, —NR18C(O)R17, —OP(O)(OR17)2) —SP(O)(OR17)2, —SR17, —S(O)pR17, —OS(O)pR17, —S(O)pOR17, —NR18S(O)pR17, or —S(O)pNR19R20; provided that when both Z groups are O and X14 is C(O)—, then neither R1 or R2 is —OR17;
each R5 is independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R12 is independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, or halo;
R17 and R18, for each occurrence, are, independently, —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl;
R19 and R20, for each occurrence, are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl, or an optionally substituted heteraralkyl; or R19 and R20, taken together with the nitrogen to which they are attached, form an optionally substituted heterocyclyl or an optionally substituted heteroaryl;
R22 and R23 are each independently N(R5)—N(R5)—C(R5)2— or —C(R5)2—N(R5)—N(R5)—; and
p is 1 or 2.

### Claim 117 (depends on 116)

The compound of claim 116, wherein R1 and R2 are each an optionally substituted aryl or an optionally substituted heteroaryl.

### Claim 118

(canceled)

### Claim 119 (depends on 116)

The compound of claim 116, wherein R1 and R2 are both an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim at position 105

120-122. (canceled)

### Claim 123 (depends on 116)

The compound of claim 116, wherein the compound is represented by formula (XV):
R3 and R4 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R6 is —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl; and
R24 and R25 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl.

### Claim 124 (depends on 123)

The compound of claim 123, wherein:
R1 and R2 are each an optionally substituted aryl or an optionally substituted heteroaryl; and
R3 and R4 are each an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim 125 (depends on 124)

The compound of claim 124, wherein
R5 is —H and R6 is —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl; and
R3 and R4 are each an alkyl group.

### Claim 126

(canceled)

### Claim 127 (depends on 123)

The compound of claim 123, wherein
R1 and R2 are both an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl;
R5 is —H; and
R6 is —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim at position 111

128-129. (canceled)

### Claim 130 (depends on 123)

The compound of claim 123, wherein R24 and R25 are each an alkyl group.

### Claim 131 (depends on 130)

The compound of claim 130, wherein R24 and R25 are each methyl or ethyl.

### Claim 132 (depends on 123)

The compound of claim 123, wherein R24 and R25 are —H.

### Claim 133 (depends on 123)

The compound of claim 123, wherein both Z groups are S.

### Claim 134 (depends on 116)

The compound of claim 116, wherein the compound is represented by formula (XVI):
R3 and R4 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl;
R6 is —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl; and
R24 and R25 are independently —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl, an optionally substituted aryl or an optionally substituted heteroaryl.

### Claim 135 (depends on 134)

The compound of claim 134, wherein:
R1 and R2 are each an optionally substituted aryl or an optionally substituted heteroaryl; and
R3 and R4 are each an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim 136 (depends on 135)

The compound of claim 135, wherein
R5 is —H and R6 is —H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl; and
R3 and R4 are each an alkyl group.

### Claim 137 (depends on 136)

The compound of claim 136, wherein R1 and R2 are each a substituted or unsubstituted phenyl group and R3 and R4 are each methyl or ethyl.

### Claim 138 (depends on 134)

The compound of claim 134, wherein
R1 and R2 are both an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl;
R5 is —H; and
R6 is —H or an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cycloalkyl, an optionally substituted cycloalkenyl, an optionally substituted heterocyclyl.

### Claim 139 (depends on 138)

The compound of claim 138, wherein R1 and R2 are both a C3-C8 cycloalkyl group optionally substituted with at least one alkyl group; R3 and R4 are both an alkyl group; and R6 is —H or methyl.

### Claim 140 (depends on 139)

The compound of claim 139, wherein R1 and R2 are both cyclopropyl or 1-methylcyclopropyl.

### Claim 141 (depends on 134)

The compound of claim 134, wherein R24 and R25 are each an alkyl group.

### Claim 142 (depends on 141)

The compound of claim 141, wherein R24 and R25 are each methyl or ethyl.

### Claim 143 (depends on 134)

The compound of claim 134, wherein R24 and R25 are —H.

### Claim 144 (depends on 134)

The compound of claim 134, wherein both Z groups are S.

### Claim 145 (depends on 1)

A pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound of claim 1.

### Claim 146 (depends on 145)

The pharmaceutical composition of claim 145, further comprising one or more additional therapeutic agents.

### Claim 147 (depends on 1)

A method of treating a subject having a proliferative disorder, said method comprising administering to the subject an effective amount of a compound of claim 1.

### Claim 148 (depends on 147)

The method of claim 147, wherein the proliferative disorder is psoriasis, Reiter's syndrome, pityriasis rubra pilaris, and hyperproliferative variants of disorders of keratinization or scleroderma, smooth muscle cell proliferation, systemic sclerosis, cirrhosis of the liver, adult respiratory distress syndrome, idiopathic cardiomyopathy, lupus erythematosus, retinopathy, diabetic retinopathy, cardiac hyperplasia, benign prostatic hyperplasia, ovarian cysts, pulmonary fibrosis, endometriosis, fibromatosis, harmatomas, lymphangiomatosis, sarcoidosis, or desmoid tumors.

### Claim at position 131

149-151. (canceled)

### Claim 152 (depends on 147)

The method of claim 147, further comprising administering to the subject an additional anticancer agent.

### Claim 153 (depends on 152)

The method of claim 152, wherein the additional anticancer agent is a microtubule stabilizer.

### Claim 154 (depends on 153)

The method of claim 153, wherein the microtubule stabilizer is selected from the group consisting of Taxol®, Taxol® analogues, Discodermolide, Epothilone A, Epothilone B, Epothilone C, Epothilone D, Epothilone E, Epothilone F, Epothilone B N-oxide, Epothilone A N-oxide, 16-aza-epothilone B, 21-aminoepothilone B, 21-hydroxyepothilone D, FR-182877, BSF-223651, AC-7739, AC-7700, Fijianolide B, Laulimalide, Caribaeoside, Caribaeolin, Taccalonolide, Eleutherobin, Sarcodictyin; Laulimalide, Dictyostatin-1, Jatrophane esters, or analogs and derivatives thereof.

### Claim at position 135

155-171. (canceled)

### Claim 172 (depends on 1)

A method of treating or preventing an Hsp70 responsive disorder, comprising administering to a subject an effective amount of a compound of claim 1.

### Claim 173 (depends on 172)

The method of claim 172, wherein the Hsp70 responsive disorder is Alzheimer′s' disease, Huntington's disease, Parkinson's disease, spongiform encelphalopathies, spinal/bulbar muscular atrophy, familial amyotrophic lateral sclerosis, atherosclerosis, cerebral trauma or spinal trauma.

### Claim at position 138

174-176. (canceled)
